15 minutes delayed
Comments
Loading...
Statera BioPharma
STABOTCEM
Statera BioPharma (STAB) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestStatera BioPharma (OTC:STAB) Stock Quotes, Forecast and News Summary
Statera BioPharma Stock (OTC: STAB) stock price, news, charts, stock research, profile.
| Open | - |
| Close | - |
| Volume / Avg. | 0 / 10.16K |
| Day Range | - - - |
| 52 Wk Range | 0.00 - 0.04 |
| Market Cap | $42.85K |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | OTC |
| RSI | 0 |
| Short Interest | - |
| Days to Cover | 2.02 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Statera BioPharma Inc
Sector
Health Care
Industry
Biotechnology
Statera BioPharma Inc is a pre-clinical and clinical biopharmaceutical company developing multiple p...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Statera BioPharma (STAB) stock?
You can purchase shares of Statera BioPharma (OTCEM:STAB) through any online brokerage.
Who are Statera BioPharma (STAB) competitors?
There are no as such competitors for Statera BioPharma.
What is the target price for Statera BioPharma (STAB) stock?
There is no analysis for Statera BioPharma.
What is the forecast for Statera BioPharma (STAB) stock?
There is no analysis for Statera BioPharma to provide a consensus price target.
Current stock price for Statera BioPharma (STAB)?
The stock price for Statera BioPharma (OTCEM: STAB) is $0.0006 last updated July 22, 2024 at 3:25 PM EDT.
Does Statera BioPharma (STAB) pay a dividend?
There are no upcoming dividends for Statera BioPharma.
When is Statera BioPharma (OTCEM:STAB) reporting earnings?
Statera BioPharma’s Q3 earnings are confirmed for Monday, November 14, 2022.
Is Statera BioPharma (STAB) going to split?
There is no upcoming split for Statera BioPharma.
What sector and industry does Statera BioPharma (STAB) operate in?
Statera BioPharma is in the Health Care sector and Biotechnology industry. They are listed on the OTCEM.